financetom
Business
financetom
/
Business
/
Wesdome Q2 Gold Production Drops 3%, Maintains 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wesdome Q2 Gold Production Drops 3%, Maintains 2025 Guidance
Jul 14, 2025 5:05 AM

07:31 AM EDT, 07/14/2025 (MT Newswires) -- Wesdome Gold Mines ( WDOFF ) reported on Monday a 3% decline in gold production for the second quarter.

For the three months ended June 30, the company produced 42,781 ounces of gold, compared with 44,035 ounces a year ago. Sales increased 15% to 45,900 ounces from 40,000 ounces.

Wesdome maintained its 2025 gold production guidance range of 190,000 to 210,000 tonnes.

The company said its production remains weighted toward the second half, with the fourth quarter expected to contribute nearly one-third of total annual output.

Wesdome will release its second-quarter financial results after markets close on Aug. 13.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Prologis Insider Sold Shares Worth $2,783,215, According to a Recent SEC Filing
Prologis Insider Sold Shares Worth $2,783,215, According to a Recent SEC Filing
Aug 27, 2025
05:37 PM EDT, 08/27/2025 (MT Newswires) -- Lori A Palazzolo, Chief Accounting Officer, Managing Director, on August 26, 2025, sold 25,000 shares in Prologis ( PLD ) for $2,783,215. Following the Form 4 filing with the SEC, Palazzolo has control over a total of 650 common shares of the company, with 414 shares held directly and 236 controlled indirectly. SEC...
Celcuity Gets US FDA Acceptance for NDA Review of Breast Cancer Drug Candidate
Celcuity Gets US FDA Acceptance for NDA Review of Breast Cancer Drug Candidate
Aug 27, 2025
05:38 PM EDT, 08/27/2025 (MT Newswires) -- Celcuity ( CELC ) said late Wednesday the US Food and Drug Administration has agreed to review its new drug application for gedatolisib under the Real-Time Oncology Review program for treating HR+/HER2- advanced breast cancer. The rolling application submission for the drug candidate is expected in September, with a completion aimed for Q4,...
Five Below Q2 Adjusted Earnings, Net Sales Rise; Lifts Fiscal 2025 Guidance
Five Below Q2 Adjusted Earnings, Net Sales Rise; Lifts Fiscal 2025 Guidance
Aug 27, 2025
05:33 PM EDT, 08/27/2025 (MT Newswires) -- Five Below ( FIVE ) reported late Wednesday Q2 adjusted earnings of $0.81 per diluted share, up from $0.54 a year ago. Analysts polled by FactSet expected $0.63. Net sales for the quarter ended Aug. 2 were $1.03 billion, up from $830.1 million a year earlier. Analysts expected $995 million. For fiscal Q3,...
EQB Reports Lower Third-Quarter Profit, Revenue; Dividend Raised 17% year-over-year
EQB Reports Lower Third-Quarter Profit, Revenue; Dividend Raised 17% year-over-year
Aug 27, 2025
05:36 PM EDT, 08/27/2025 (MT Newswires) -- EQB (EQB.TO), the parent company of Equitable Bank, after trade Wednesday said its third-quarter profit and revenue declined year-over-year due to macroeconomic pressures as it boosted its provision for credit losses (PCL) while hiking its dividend.. The company earned $80.26 million, or $2.07 per share, in the period, down from $117.18 million, or...
Copyright 2023-2026 - www.financetom.com All Rights Reserved